AzTrials
AzTrials

Swallowing DisorderDYSPHAGING-PNCT05734586

Screening for Sarcopenic Dysphagia and the Implementation of Measures to Prevent Its Complications in Geriatric Patients [DYSPHAGING-PILOT]

A study testing EAT-10 (Eating assessment Tool) screening questionnaire and Protective measures for the upper airways in people with Swallowing Disorder and Sarcopanic Dysphagia, run by Hospices Civils de Lyon at 1 site in France.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

Sarcopenic dysphagia is described as a swallowing disorder caused by a loss of muscle mass and strength, sarcopenia. It induces chronic complications like micro-inhalations and the worsening of chronic undernutrition, according to a vicious circle. Read more about this study

Who is it for?
Ages 70 years and older
Conditions the study is for
Swallowing Disorder, Sarcopanic Dysphagia
What is being tested?
EAT-10 (Eating assessment Tool) screening questionnaire and Protective measures for the upper airways
Type of treatment
Surgery or procedure
Could I receive a placebo?
No, everyone receives an active treatment
How many people
102 participants
Where
1 siteFrance
Study dates
1 Jun 2023to 1 Oct 2024
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 70 years and older
  • All sexes
  • No healthy volunteers
  • Older adult

Who may be able to join

  • Patient aged ≥ 70 years,
  • Patient affiliated to a social security system,
  • Patient hospitalized in the health sector or in a medico-social institute,
  • Patient informed of the study (information leaflet provided) and having orally signified their consent to inclusion in the study.
  • Patient under legal protection, guardianship or curatorship,

Who cannot join

  • Patient unable to feed orally,
  • Patient with an active pathology responsible for acute swallowing disorders (< 3 months) (neurodegenerative pathology with predominant motor impairment such as Charcot's disease, stroke, ENT disease).
  • Patient unable to answer the questionnaire.

Trial locations and contacts

1 site in 1 country.

France1 site, 1 recruiting
  • Centre Hospitalier Lyon Sud - Court Séjour Gériatrique

    Lyon, 69495

    Marion MERDINIAN, Dr, 00 33 4 78 86 56 83, marion.merdinian@chu-lyon.fr

    Recruiting

Other trials in France

About this study

Official title: Feasibility Study of Screening for Sarcopenic Dysphagia and the Implementation of Measures to Prevent Its Complications in Geriatric or Institutionalized Patients Aged ≥ 70 Years.

Sarcopenic dysphagia is described as a swallowing disorder caused by a loss of muscle mass and strength, sarcopenia. It induces chronic complications like micro-inhalations and the worsening of chronic undernutrition, according to a vicious circle. Awareness of the high prevalence of sarcopenic dysphagia and its serious consequences among elderly people with disabilities and hospitalized patients is recent, which explains the low rate of screening in the population concerned. In this context, methods of prevention, evaluation and intervention of sarcopenic dysphagia adapted to the most exposed population are needed.

Two European learned societies have developed recommendations that include increased awareness of swallowing disorders, the use of screening scores, preventive measures, diagnostic standardization, and implemented interventions (rehabilitation, textural adaptation, etc.). In order to respect these recommendations, a pedagogical sheet, entitled DYSPHAGING was elaborated within our unit in a multiprofessional way in 4 steps (1 - Screen; 2 - Protect; 3 - Confirm; 4 - Rehabilitate).

This feasibility study aims to evaluate the rate of completion and the conditions for implementing steps 1 and 2 in hospital and institutional care units.

Read the detailed description

Sarcopenic dysphagia is described as a swallowing disorder caused by a loss of muscle mass and strength, sarcopenia. It induces chronic complications like micro-inhalations and the worsening of chronic undernutrition, according to a vicious circle. Awareness of the high prevalence of sarcopenic dysphagia and its serious consequences among elderly people with disabilities and hospitalized patients is recent, which explains the low rate of screening in the population concerned. In this context, methods of prevention, evaluation and intervention of sarcopenic dysphagia adapted to the most exposed population are needed.

Two European learned societies have developed recommendations that include increased awareness of swallowing disorders, the use of screening scores, preventive measures, diagnostic standardization, and implemented interventions (rehabilitation, textural adaptation, etc.). In order to respect these recommendations, a pedagogical sheet, entitled DYSPHAGING was elaborated within our unit in a multiprofessional way in 4 steps (1 - Screen; 2 - Protect; 3 - Confirm; 4 - Rehabilitate).

This feasibility study aims to evaluate the rate of completion and the conditions for implementing steps 1 and 2 in hospital and institutional care units.

Being tested
EAT-10 (Eating assessment Tool) screening questionnaire, Protective measures for the upper airways
Keywords
Prevention, Nutrition, Re-education
Medical subject headings
Deglutition Disorders

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • EAT-10 (Eating assessment Tool) screening questionnaireOther

    After inclusion, issuance of the EAT-10 screening questionnaire for swallowing disorders by the healthcare team

  • Protective measures for the upper airwaysProcedure or surgery

    In the event of an EAT ≥2 score, immediate implementation or within three days by the healthcare team of protective measures for the upper airways in 3 sectors:

    1: Postural maneuvers; 2: Hygienodietetic rules; 3: Food textures

Study groups in NCT05734586
Study groupRoleWhat they receive
DYSPHAGING Interventional groupOther* Step 1: delivery of the EAT-10 questionnaire for swallowing disorders screening; * Step 2: in case of EAT≥2 score, immediate implementation of upper airway protection measures in 3 areas: 1: Postural adjustments; 2 : Hygienic and dietary rules ; 3: Food textures The hypothesis is that allied health professionals in acute geriatric wards, rehabilitation units, and Long Term Care Units are able to implement the current recommendations for screening for sarcopenic dysphagia and to implement preventive measures but in a systematic way. Patient characteristics will be collected at each site at the end of the study by a clinical research assistant based on their medical records. At the end of the study, each allied health professionals who has been involved in the care of at least one patient will fill out a satisfaction questionnaire.
Receives: Other: EAT-10 (Eating assessment Tool) screening questionnaire; Procedure: Protective measures for the upper airways

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Proportion of complete achievement of steps 1 and 2

    The judgment criterion is validated if

    1. Stage 1 is performed and the EAT-10 < 2 or if
    2. Stage 1 is performed with an EAT-10 ≥ 2 and stage 2 is performed within 3 days after stage 1

    Measured: Three days

Secondary outcomes (6)
  1. Percentage of eligible patients refusing to participate in the study

    Number of eligible patients who refused to participate in the study

    Measured: 18 months

  2. Age, gender, comorbidities (CIRS-G), autonomy (ADL, IADL), co-medications

    Patient characteristics will be collected at each site at the end of the study by a clinical research assistant based on their medical records.

    Measured: 19 months

  3. Rate of partial completion of the protocol

    Proportion of non-performance of step 1 and/or step 2 within the time limit. Proportion of steps 2 carried out incompletely), description of the reasons

    Measured: 19 months

  4. Diagnosis of undernutrition and/or neurocognitive disorders and/or patent lung infection and/or COPD described in the patient's medical file, nutritional risk situation assessed by the Mini Nutritional Assessment® (MNA)

    Patient characteristics will be collected at each site at the end of the study by a clinical research assistant based on their medical records.

    Measured: 19 months

  5. Composition and disciplines of the care team

    At the end of the study, all data on the each allied health professionals will be collected on the dysphaging sheet

    Measured: 19 months

  6. Caregiver satisfaction (Likert scale).

    At the end of the study, each allied health professionals who has been involved in the care of at least one patient will fill out a satisfaction questionnaire.

    Measured: 19 months

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted21 Feb 2023
  2. Study start1 Jun 2023
  3. Primary completion1 Sep 2024 (estimated)
  4. Study completion1 Oct 2024 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Other
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrolment
102 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT05734586
Sponsor's protocol ID
69HCL22_0474
Acronym
DYSPHAGING-P
Status last verified
Jan 2024
First submitted
27 Jan 2023
Last updated
25 Jan 2024
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No

Publications

  • Masse-Deragon N, Tripoz-Dit-Masson S, Grehalle C, Subtil F, Rouze H, Grilot C, Merazga S, Goldet K, Durlach O, Schir S, Haution-Bitker M, Merdinian M, Falandry C. Adaptation and evaluation of a food preference assessment tool for older adults in geriatric care: the DYSPHAGING Preferences study protocol. BMJ Open. 2026 Sep 25;16(9):e120395. doi: 10.1136/bmjopen-2026-120395.

    PubMed 42790906
  • Durlach O, Tripoz-Dit-Masson S, Masse-Deragon N, Subtil F, Niasse-Sy Z, Herledan C, Guittard L, Goldet K, Merazga S, Chabert M, Suel A, Dayde D, Merdinian M, Falandry C. Feasibility of a screening and prevention procedure for risks associated with dysphagia in older patients in geriatric units: the DYSPHAGING pilot study protocol. BMJ Open. 2024 Apr 19;14(4):e081333. doi: 10.1136/bmjopen-2023-081333.

    PubMed 38642998

Questions about this trial

What is this clinical trial studying?

A study testing EAT-10 (Eating assessment Tool) screening questionnaire and Protective measures for the upper airways in people with Swallowing Disorder and Sarcopanic Dysphagia, run by Hospices Civils de Lyon at 1 site in France.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 5 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 25 Jan 2024. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in France. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Contact Marion MERDINIAN, Dr (00 33 4 78 86 56 83, marion.merdinian@chu-lyon.fr), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Proportion of complete achievement of steps 1 and 2 (time frame: Three days). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT05734586, which also lists 2 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 25 Jan 2024.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in